INmune Bio, Inc.
INMB
$7.30
-$0.20-2.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.80M | -42.08M | -41.27M | -37.74M | -34.50M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 45.00K | 79.00K | 118.00K | 157.00K | 191.00K |
| Total Other Non-Cash Items | 7.90M | 7.61M | 7.73M | 7.90M | 7.41M |
| Change in Net Operating Assets | 140.00K | 1.04M | 7.68M | 6.66M | 8.58M |
| Cash from Operations | -32.71M | -33.36M | -25.75M | -23.03M | -18.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.50M | -10.00M | -10.00M | -10.00M | -7.50M |
| Issuance of Common Stock | 33.49M | 28.21M | 27.79M | 16.27M | 775.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.99M | 18.21M | 17.79M | 6.27M | -6.73M |
| Foreign Exchange rate Adjustments | 59.00K | 224.00K | -301.00K | -1.00K | 39.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.67M | -14.93M | -8.26M | -16.76M | -25.00M |